Evidence map›Paper›PMID 26584588›Full record

ArticleScientific reports2015

The human decapping scavenger enzyme DcpS modulates microRNA turnover.

Oussama Meziane, Sandra Piquet, Gabriel D Bossé, Dominic Gagné, Eric Paquet, Claude Robert, Michael A Tones, Martin J Simard

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. AtXRN4 Affects the Turnover of Chosen miRNA*s inPlants (Basel, Switzerland) · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Oussama MezianeSt-Patrick Research Group in Basic Oncology, Centre Hospitalier Universitaire de Québec-Université Laval (Hôtel-Dieu de Québec), Laval University Cancer Research Centre, Quebec City, Québec, Canada.
Sandra PiquetSt-Patrick Research Group in Basic Oncology, Centre Hospitalier Universitaire de Québec-Université Laval (Hôtel-Dieu de Québec), Laval University Cancer Research Centre, Quebec City, Québec, Canada.
Gabriel D BosséSt-Patrick Research Group in Basic Oncology, Centre Hospitalier Universitaire de Québec-Université Laval (Hôtel-Dieu de Québec), Laval University Cancer Research Centre, Quebec City, Québec, Canada.
Dominic GagnéLaboratoire de génomique fonctionnelle du développement embryonnaire, Centre de recherche en biologie de la reproduction, Pavillon Comtois, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Quebec City, Québec, Canada.
Eric PaquetSt-Patrick Research Group in Basic Oncology, Centre Hospitalier Universitaire de Québec-Université Laval (Hôtel-Dieu de Québec), Laval University Cancer Research Centre, Quebec City, Québec, Canada.
Claude RobertLaboratoire de génomique fonctionnelle du développement embryonnaire, Centre de recherche en biologie de la reproduction, Pavillon Comtois, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Quebec City, Québec, Canada.
Michael A TonesRare Disease Research Unit, Pfizer, 610 Main Street, Cambridge, Massachusetts, USA.
Martin J SimardSt-Patrick Research Group in Basic Oncology, Centre Hospitalier Universitaire de Québec-Université Laval (Hôtel-Dieu de Québec), Laval University Cancer Research Centre, Quebec City, Québec, Canada.
Université Laval · CAHôtel-Dieu de Québec · CACentre hospitalier universitaire de Québec · CAPfizer (United States) · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The decapping scavenger enzyme DcpS is known for its role in hydrolyzing the cap structure following mRNA degradation. Recently, we discovered a new function in miRNA degradation activation for the ortholog of DcpS in C. elegans. Here we show that human DcpS conserves its role in miRNA turnover. In human cells, DcpS is a nucleocytoplasmic shuttling protein that activates miRNA degradation independently of its scavenger decapping activity in the cytoplasmic compartment. We also demonstrate that this new function for DcpS requires the contribution of the 5'-3' exonuclease Xrn2. Our findings support a conserved role of DcpS as a modulator of miRNA turnover in animals.

Indexed as

Active Transport, Cell NucleusAmino Acid SequenceBlotting, NorthernBlotting, WesternCell NucleusEndoribonucleasesFluorescent Antibody TechniqueGene Expression ProfilingHEK293 CellsHumansMicroRNAsMolecular Sequence DataMutationOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionRNA CapsDcpS protein, humanEndoribonucleasesMicroRNAsRNA Caps

Identifiers

PMID26584588
PMCPMC4653633
OpenAlexW2473539078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.